期刊文献+

不同浓度肝素液封管对血液透析患者的影响 被引量:2

下载PDF
导出
摘要 目的:探讨不同浓度肝素液封管对血液透析行颈内静脉双腔导管患者短期凝血指标及导管使用情况的影响。方法:将120例行颈内静脉双腔导管的血液透析患者随机分为观察组和对照组各60例,两组给予相同的置管操作方法,观察组给予高浓度肝素钠封管,对照组给予低浓度肝素钠;比较两组使用肝素液封管后短期凝血指标、导管使用情况。结果:观察组使用高浓度肝素钠封管后30 min优于基础值(P<0.05);观察组导管使用状况优于对照组(P<0.05)。结论:给予血液透析行颈内静脉双腔导管患者高浓度肝素钠液封管,发生不良反应少,值得推广应用。
作者 喻小清
机构地区 梧州市人民医院
出处 《齐鲁护理杂志》 2014年第19期97-99,共3页 Journal of Qilu Nursing
  • 相关文献

参考文献4

二级参考文献10

  • 1林新广,李健,王玉柱.血液透析病人中心静脉插管常见并发症及处理[J].中国血液净化,2002,1(2):51-55. 被引量:44
  • 2丁瑾.深静脉留置导管纯肝素封管在血液透析中的应用体会[J].中国血液净化,2006,5(7):404-404. 被引量:11
  • 3Trivedi HS, Twardowski ZJ. Use of double-lumen dialysis catheters. Loading with locked heparin. ASAIO J, 1997,43: 900-903.
  • 4Sonawane S, Kasbekar N, Berns JS. The safety of heparins in end-stage renal disease. Semin Dial, 2006,19: 305- 310.
  • 5Boyd A, Dunne A, Townsend K, et al. Sampling for international normalized ratios in patients on hemodialysis with central venous catheters. Nephrol Nurs J, 2006,33:408-411.
  • 6Sombolos KI, Fragia TK, Bamichas GI, et al. Heparin solution locked in acute hemodialysis catheters: impact on activated partial thromboplastin time. ASAIO J, 2003,49:287-289.
  • 7Agharazii M, Plamondon I, Lebel M, et al. Estimation of heparin leak into the systemic circulation after central venous catheter heparin lock. Nephrol Dial Transplant, 2005,20:1238-1240.
  • 8Mandolfo S, Borlandelli S, Elli A. Catheter lock solutions: it's time for a change. J Vasc Access, 2006,7:99-102.
  • 9[3]宋逢春,于宗周.血液净化外科学.湖北科学技术出版社,1992:49.
  • 10毛晓玲,郁知非,韦宏成,郑绮宜,陈湛华.血液透析时肝素相关性血小板减少症[J].中华血液学杂志,1999,20(3):161-161. 被引量:6

共引文献15

同被引文献21

  • 1丁秀和,丁春华,闫现花,吕凤菊,闵庆虹,刘海丽,郑明华.肝素钠尿激酶混合液在血液透析长期留置导管封管中的应用[J].中国误诊学杂志,2009,9(5):1028-1029. 被引量:5
  • 2苏庆玲.无肝素技术在血液透析治疗中的应用及护理[J].中国血液净化,2004,3(11):634-635. 被引量:15
  • 3谢小华.维持性血液透析患者静脉留置针的临床观察[J].中国实用护理杂志(下旬版),2005,21(2):36-37. 被引量:32
  • 4Rossignol P,Dorval M,Fay R,et al.Rationale and design of the Hep Zero study:a prospective,multicenter,international,open,randomized,controlled clinical study with parallel groups comparing heparin-free dialysis with heparin-coated dialysis membrane(Evodial)versus standard care:study protocol for a randomized controlled trial[J].Trials,2013,14:163.
  • 5Lameire N,Kellum J A.Contrast-induced acute kidney injury and renal support for acute kidney injury:a KDIGO summary(Part2)[J].Critical Care,2013,17(1):205.
  • 6Shen J I,Winkelmayer W C.Use and Safety of Unfractionated Heparin for Anticoagulation During Maintenance Hemodialysis.American journal of kidney diseases:the official journal of the National Kidney Foundation[J].2012,60(3):473.
  • 7Monagle P,Chan A K C,Goldenberg N A,et al.Antithrombotic Therapy in Neonates and Children:Antithrombotic Therapy and Prevention of Thrombosis,9th ed:American College of Chest Physicians Evidence-Based Clinical Practice Guidelines[J].Chest,2012,141(2 Suppl):e737S.
  • 8Fran ois K,Wissing K M,Jacobs R.Avoidance of systemic anticoagulation during intermittent haemodialysis with heparingrafted polyacrilonitrile membrane and citrate-enriched dialysate:a retrospective cohort study[J].BMC Nephrology,2014,15:104.
  • 9Rhee C M,Unruh M,Chen J.Infrequent Dialysis:A New Paradigm for Hemodialysis Initiation[J].Seminars in dialysis,2013,26(6):10.
  • 10王芳,向明芳,胡秀容.肝素钠稀释液在口腔颌面癌联合根治术后鼻气管插管护理中的应用[J].中华现代护理杂志,2009,15(10):957-958. 被引量:2

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部